{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:29:29Z","timestamp":1790688569037,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The pathogenesis of non-small cell lung cancer (NSCLC) is complex. This research focuses on the expression, function, and molecular mechanisms of miR-4513 in NSCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A total of 126 matched tissue pairs (NSCLC and adjacent normal) were collected, along with assessment of miR-4513 and VIPR1 expression in multiple cell lines (A549, H1299, BEAS-2B) by qRT-PCR. In vitro, the influence of miR-4513 on cellular phenotypes was assessed by determining proliferation rates through CCK-8 assay and quantifying migration\/invasion capacities via Transwell systems. Targetscan predicted the targeting relationship between miR-4513 and VIPR1, which was subsequently confirmed by dual-luciferase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of miR-4513 is upregulated in NSCLC tissues. The high expression of miR-4513 is associated with pathological features. Survival analysis revealed that high expression of miR-4513 was an independent predictor of unfavorable clinical outcomes in NSCLC patients. In vitro, overexpression of miR-4513 can promote the proliferation, migration and invasion of NSCLC cells, while inhibition of its expression has the opposite effect. VIPR1 overexpression significantly inhibited the proliferation and invasion of NSCLC cells, confirming its tumor-suppressive role. Furthermore, miR-4513 can directly bind to the 3\u2019UTR region of the VIPR1 gene and show a negative correlation with it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High expression of miR-4513 may serve as a potential biomarker for poor prognosis in NSCLC patients. In addition, miR-4513 may promote the malignant progression of NSCLC by targeting VIPR1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00688-5","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:07:42Z","timestamp":1779962862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miR-4513 promotes the proliferation and metastasis of non-small cell lung cancer cells by targeting VIPR1"],"prefix":"10.1186","volume":"163","author":[{"given":"Zhonghao","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanwu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"2","key":"688_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ijc.32739","volume":"147","author":"S Yang","year":"2020","unstructured":"Yang S, Tang D, Zhao YC, Liu H, Luo S, Stinchcombe TE, et al. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival. Int J Cancer. 2020;147(2):392\u2013403.","journal-title":"Int J Cancer"},{"issue":"6","key":"688_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41419-018-0733-4","volume":"9","author":"RZ Li","year":"2018","unstructured":"Li RZ, Fan XX, Duan FG, Jiang ZB, Pan HD, Luo LX, et al. Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation. Cell Death Dis. 2018;9(6):696.","journal-title":"Cell Death Dis"},{"issue":"11","key":"688_CR3","doi-asserted-by":"publisher","first-page":"e1461303","DOI":"10.1080\/2162402X.2018.1461303","volume":"7","author":"R Wang","year":"2018","unstructured":"Wang R, Yang L, Zhang C, Wang R, Zhang Z, He Q, et al. Th17 cell-derived IL-17A promoted tumor progression via STAT3\/NF-\u03baB\/Notch1 signaling in non-small cell lung cancer. Oncoimmunology. 2018;7(11):e1461303.","journal-title":"Oncoimmunology"},{"issue":"3","key":"688_CR4","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1080\/21655979.2021.1977105","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Hu Q, Zhang J, Jin Z, Ruan Y, Xia L, et al. Silencing of A-kinase anchor protein 4 inhibits the metastasis and growth of non-small cell lung cancer. Bioengineered. 2022;13(3):6895\u2013907.","journal-title":"Bioengineered"},{"issue":"1","key":"688_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5114\/kitp.2015.50563","volume":"12","author":"M Kasprzyk","year":"2015","unstructured":"Kasprzyk M, S\u0142awi\u0144ski G, Musik M, Marciniak \u0141, Dyszkiewicz W, Piwkowski C, et al. Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer. Kardiochirurgia i torakochirurgia polska = Pol J cardio-thoracic Surg. 2015;12(1):18\u201325.","journal-title":"Kardiochirurgia i torakochirurgia polska = Pol J cardio-thoracic Surg"},{"issue":"7","key":"688_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2017.04.011","volume":"12","author":"K Chansky","year":"2017","unstructured":"Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Valli\u00e8res E, Groome P, et al. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer. J Thorac oncology: official publication Int Association Study Lung Cancer. 2017;12(7):1109\u201321.","journal-title":"J Thorac oncology: official publication Int Association Study Lung Cancer"},{"issue":"7","key":"688_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/thoraxjnl-2018-212638","volume":"74","author":"VK Raghu","year":"2019","unstructured":"Raghu VK, Zhao W, Pu J, Leader JK, Wang R, Herman J, et al. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models. Thorax. 2019;74(7):643\u20139.","journal-title":"Thorax"},{"issue":"12","key":"688_CR8","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-14-0109","volume":"74","author":"EA Math\u00e9","year":"2014","unstructured":"Math\u00e9 EA, Patterson AD, Haznadar M, Manna SK, Krausz KW, Bowman ED, et al. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res. 2014;74(12):3259\u201370.","journal-title":"Cancer Res"},{"issue":"2","key":"688_CR9","first-page":"173","volume":"6","author":"R Wang","year":"2016","unstructured":"Wang R, Chen X, Xu T, Xia R, Han L, Chen W, et al. MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR. Am J cancer Res. 2016;6(2):173\u201386.","journal-title":"Am J cancer Res"},{"issue":"8","key":"688_CR10","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1111\/jcmm.14404","volume":"23","author":"H Feng","year":"2019","unstructured":"Feng H, Ge F, Du L, Zhang Z, Liu D. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4. J Cell Mol Med. 2019;23(8):5282\u201391.","journal-title":"J Cell Mol Med"},{"key":"688_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1476-4598-13-245","volume":"13","author":"MX Liu","year":"2014","unstructured":"Liu MX, Zhou KC, Cao Y. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Mol Cancer. 2014;13:245.","journal-title":"Mol Cancer"},{"issue":"9","key":"688_CR12","first-page":"3821","volume":"23","author":"YX Xu","year":"2019","unstructured":"Xu YX, Sun J, Xiao WL, Liu YS, Yue J, Xue LF, et al. MiR-4513 mediates the proliferation and apoptosis of oral squamous cell carcinoma cells via targeting CXCL17. Eur Rev Med Pharmacol Sci. 2019;23(9):3821\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"688_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41374-018-0164-y","volume":"99","author":"N Zhang","year":"2019","unstructured":"Zhang N, Li Y, Zheng Y, Zhang L, Pan Y, Yu J, et al. miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs. Lab Invest. 2019;99(4):568\u201376.","journal-title":"Lab Invest"},{"issue":"6","key":"688_CR14","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.bmcl.2012.01.082","volume":"22","author":"LS Harikrishnan","year":"2012","unstructured":"Harikrishnan LS, Srivastava N, Kayser LE, Nirschl DS, Kumaragurubaran K, Roy A et al. Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1). Bioorganic & medicinal chemistry letters. 2012;22(6):2287\u201390.","journal-title":"Bioorganic &amp; medicinal chemistry letters."},{"issue":"5","key":"688_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/07357900903476752","volume":"28","author":"V Mlakar","year":"2010","unstructured":"Mlakar V, Strazisar M, Sok M, Glavac D. Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1. Cancer Invest. 2010;28(5):487\u201394.","journal-title":"Cancer Invest"},{"key":"688_CR16","doi-asserted-by":"publisher","first-page":"1610455","DOI":"10.3389\/pore.2022.1610455","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Wu H, Hu W, Zhang H, Li A, Zhang Z, et al. Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population. Pathol Oncol research: POR. 2022;28:1610455.","journal-title":"Pathol Oncol research: POR"},{"issue":"23","key":"688_CR17","doi-asserted-by":"publisher","first-page":"14263","DOI":"10.18632\/aging.205300","volume":"15","author":"B Jiang","year":"2023","unstructured":"Jiang B, Yang J, He R, Wang D, Huang Y, Zhao G, et al. Integrated multi-omics analysis for lung adenocarcinoma in Xuanwei, China. Aging. 2023;15(23):14263\u201391.","journal-title":"Aging"},{"issue":"4","key":"688_CR18","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/jcmm.16215","volume":"25","author":"X Liu","year":"2021","unstructured":"Liu X, Liu L, Chen K, Sun L, Li W, Zhang S. Huaier shows anti-cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K\/AKT\/HIF-1\u03b1 pathway. J Cell Mol Med. 2021;25(4):2228\u201337.","journal-title":"J Cell Mol Med"},{"issue":"20","key":"688_CR19","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"688_CR20","doi-asserted-by":"publisher","first-page":"25564","DOI":"10.18632\/aging.104163","volume":"12","author":"S Liu","year":"2020","unstructured":"Liu S, Tian Y, Zheng Y, Cheng Y, Zhang D, Jiang J, et al. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-\u03b2-catenin signaling. Aging. 2020;12(24):25564\u201380.","journal-title":"Aging"},{"issue":"3","key":"688_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/humc.2019.094","volume":"30","author":"H Ding","year":"2019","unstructured":"Ding H, Shi Y, Liu X, Qiu A. MicroRNA-4513 Promotes Gastric Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Targeting KAT6B. Hum gene therapy Clin Dev. 2019;30(3):142\u20138.","journal-title":"Hum gene therapy Clin Dev"},{"key":"688_CR22","doi-asserted-by":"publisher","first-page":"673501","DOI":"10.3389\/fgene.2021.673501","volume":"12","author":"H Zuo","year":"2021","unstructured":"Zuo H, Li X, Zheng X, Sun Q, Yang Q, Xin Y. A Novel circRNA-miRNA-mRNA Hub Regulatory Network in Lung Adenocarcinoma. Front Genet. 2021;12:673501.","journal-title":"Front Genet"},{"key":"688_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12967-015-0503-3","volume":"13","author":"W Xu","year":"2015","unstructured":"Xu W, Ying Y, Shan L, Feng J, Zhang S, Gao Y, et al. Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer. J translational Med. 2015;13:153.","journal-title":"J translational Med"},{"key":"688_CR24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fonc.2019.00790","volume":"9","author":"H Duan","year":"2019","unstructured":"Duan H, Lei Z, Xu F, Pan T, Lu D, Ding P, et al. PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer. Front Oncol. 2019;9:790.","journal-title":"Front Oncol"},{"issue":"8","key":"688_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1759-7714.13904","volume":"12","author":"X Tang","year":"2021","unstructured":"Tang X, Ding H, Liang M, Chen X, Yan Y, Wan N, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac cancer. 2021;12(8):1219\u201330.","journal-title":"Thorac cancer"},{"issue":"3","key":"688_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3892\/ol.2015.2873","volume":"9","author":"C Chen","year":"2015","unstructured":"Chen C, Zhao Z, Liu Y, Mu D. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells. Oncol Lett. 2015;9(3):1128\u201334.","journal-title":"Oncol Lett"},{"key":"688_CR27","doi-asserted-by":"crossref","unstructured":"Luo X, Zhang X, Peng J, Chen Y, Zhao W, Jiang X et al. miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI. Biosci Rep. 2020;40(11).","DOI":"10.1042\/BSR20200163"},{"issue":"4","key":"688_CR28","first-page":"2431","volume":"11","author":"Y Li","year":"2019","unstructured":"Li Y, Zhu H, Wang J, Qian X, Li N. miR-4513 promotes breast cancer progression through targeting TRIM3. Am J translational Res. 2019;11(4):2431\u20138.","journal-title":"Am J translational Res"},{"key":"688_CR29","doi-asserted-by":"publisher","first-page":"1408000","DOI":"10.3389\/fgene.2024.1408000","volume":"15","author":"N Bao","year":"2024","unstructured":"Bao N, Zhang X, Lin C, Qiu F, Mo G. A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC. Front Genet. 2024;15:1408000.","journal-title":"Front Genet"},{"issue":"1","key":"688_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12575-025-00275-4","volume":"27","author":"H Li","year":"2025","unstructured":"Li H, Jin X, Li W, Ren F, Li T, Li X, et al. Construction of a circRNA-miRNA-mRNA Regulatory Network for the Immune Regulation of Lung Adenocarcinoma. Biol procedures online. 2025;27(1):13.","journal-title":"Biol procedures online"},{"key":"688_CR31","doi-asserted-by":"crossref","unstructured":"Zhao L, Yu Z, Zhao B. Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells. Medical oncology (Northwood, London, England). 2019;36(11):91.","DOI":"10.1007\/s12032-019-1312-y"},{"issue":"8","key":"688_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.21037\/atm.2020.04.38","volume":"8","author":"L Sun","year":"2020","unstructured":"Sun L, Zhang Z, Yao Y, Li WY, Gu J. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model. Annals translational Med. 2020;8(8):550.","journal-title":"Annals translational Med"},{"issue":"1","key":"688_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43046-024-00236-0","volume":"36","author":"Z Davoodi-Moghaddam","year":"2024","unstructured":"Davoodi-Moghaddam Z, Jafari-Raddani F, Kordasti S, Bashash D. Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors. J Egypt Natl Cancer Inst. 2024;36(1):30.","journal-title":"J Egypt Natl Cancer Inst"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00688-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:30:23Z","timestamp":1785454223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00688-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00688-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Third People\u2019s Hospital of Yuhang District. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"83"}}